...
首页> 外文期刊>Cytotechnology >Prolonged lidocaine metabolizing activity of primary hepatocytes with spheroid culture using polyurethane foam as a culture substratum
【24h】

Prolonged lidocaine metabolizing activity of primary hepatocytes with spheroid culture using polyurethane foam as a culture substratum

机译:以聚氨酯泡沫为培养基质的球体培养可延长原代肝细胞的利多卡因代谢活性

获取原文

摘要

Primary rat hepatocytes formed spheroids in the pores of polyurethane foam (PUF) used as a culture substratum. The hepatocytes in monolayer and spheroid stationary culture converted lidocaine to monoethylglycinexylidide (MEGX) which was N-deethylation of lidocaine. The metabolic activity of the hepatocytes/spheroid stationary culture system was 1.5~2.0-fold higher than that of monolayer culture for 10 days. The activity of albumin production and cell survival of hepatocytes in monolayer and spheroid cultures decrease due to lidocaine treatment dependend on the lidocaine concentration, but the activity and cell survival in PUF/spheroid stationary culture were maintained at a higher level than that in monolayer culture under the lidocaine treatment. We developed a device for an in vitro liver model, drug metabolism simulator (DMS), using a PUF/spheroid packed-bed module including 4.00 ± 0.68 × 107 hepatocytes and analyzed pharmacokinetics of lidocaine in a one-compartment model. Lidocaine clearance and extraction ratio of hepatocytes in the DMS corresponded to 1.354 ± 0.318 ml/min/g-liver and 0.677 ± 0.0159/g-liver, respectively (N=4). These values were comparable with in vivo values, 1.930 ml/min g-liver and 0.965/g-liver reported by Nyberg (1977). Consequently, PUF/spheroid culture maintained high lidocaine metabolizing activity over a long term and seems to provide a promising culture system as a drug metabolism simulator which will be used for drug screening, cytotoxicity tests and prediction of pharmacokinetics.
机译:大鼠原代肝细胞在用作培养基质的聚氨酯泡沫(PUF)的孔中形成球体。单层和球状固定培养物中的肝细胞将利多卡因转化为单乙基甘氨糖苷(MEGX),这是利多卡因的N-脱乙基。肝细胞/球体固定培养系统10天的代谢活性比单层培养高1.5〜2.0倍。利多卡因的处理依赖于利多卡因的浓度,使单层和球状培养物中白蛋白产生的活性和肝细胞的细胞存活率降低,但PUF /球状静止培养物中的白蛋白产生活性和细胞存活率保持在比单层培养下更高的水平。利多卡因治疗。我们使用包含4.00±0.68×107肝细胞的PUF /球状填充床模块开发了用于体外肝模型的设备,即药物代谢模拟器(DMS),并在单室模型中分析了利多卡因的药代动力学。 DMS中的利多卡因清除率和肝细胞提取率分别对应于1.354±0.318 ml / min / g肝脏和0.677±0.0159 / g肝脏(N = 4)。这些值与体内值相当,Nyberg(1977)报道其为1.930 ml / min g-liver和0.965 / g-liver。因此,PUF /球体培养物长期保持了较高的利多卡因代谢活性,并且似乎提供了一种有前途的培养系统作为药物代谢模拟器,可用于药物筛选,细胞毒性测试和药代动力学预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号